Tag

heart defect Archives - Carey Danis & Lowe

Zofran Birth Defect Lawsuits: Carey Danis & Lowe Investigating Cases

By | Pharmaceutical litigation, Uncategorized, Zofran

zofranCarey Danis & Lowe is currently investigating Zofran birth defect cases, and is assisting families with filing Zofran birth defect lawsuits.

Zofran is an anti-nausea drug manufactured by GlaxoSmithKline, and was originally intended to prevent nausea and vomiting in patients undergoing chemotherapy.

Ondansetron, the active ingredient in Zofran, has been linked to birth defects in children.

Swedish Study

A Swedish study, published in Reproductive Toxicology in December 2014, found that children exposed to Zofran in the womb had double the risk of developing a heart defect. The researchers also discovered that the most common heart defect was a hole in the heart, also known as an atrial or ventricular septal defect.

BioMed Study

Another study published in 2013 by BioMed Research International found a 20% increased risk of children developing major birth defects if exposed to Zofran in the first trimester of pregnancy. Still, the researchers noted that they could not make a firm determination on the safety of Zofran for pregnant women based on their results.

LeClair Zofran Birth Defect Lawsuit

Tomisha LeClair filed a Zofran birth defect lawsuit after her child was born with an atrial septal defect, among many other birth defects that included facial dysmorphia and hearing loss.

LeClair claimed that her child’s birth defects resulted from exposure to Zofran in the womb.

Many women like LeClair, along with their families, have filed lawsuits against GlaxoSmithKline. These lawsuits assert that the pharmaceutical giant marketed Zofran to pregnant women, and made the anti-nausea drug appear to be safe to use.

However, as these women discovered, Zofran is not safe for pregnant mothers and their unborn children.

You are not alone. You don’t have to suffer in silence.

The team of experienced Zofran lawyers at Carey Danis & Lowe work to recover losses for people like you. Contact our law firm for a free case evaluation. One of our Zofran lawyers can guide you through your legal options, and whether filing a Zofran birth defect lawsuit is right for you.

You can reach our law firm by phone at 800.721.2519, or by completing a confidential personal injury claim form.

Evidence Strengthens Link Between SSRI Antidepressants and Congenital Birth Defects

By | Lexapro, Paxil, Pharmaceutical litigation, Uncategorized, Zoloft

zoloft_heart_birth_defect_ssri_pregnancyAccording to a European health care expert, pregnant women who take a selective serotonin reuptake inhibitor (SSRI) antidepressant early in pregnancy increase their child’s risk twofold of developing a heart defect. Professor Stephen Pilling of the National Institute for Health and Care Excellence (NICE) recently told the BBC that the birth defects risks associated with SSRI antidepressants are on par, if not more severe, than those linked to alcohol or tobacco use by pregnant women.

Pilling went on to state that the warnings communicated to pregnant women taking an SSRI antidepressant will soon be updated to include information about the strong link between SSRIs and birth defects. In Pilling’s opinion, the risk of heart defects outweighs, in some cases, the risk to the pregnant mother in terms of whether to discontinue use of an SSRI antidepressant in early pregnancy.

Carey Danis & Lowe is a national law firm with attorneys that represent women and their families in SSRI birth defects lawsuits. Our SSRI birth defects lawyers view Pilling’s statements as positive news for women and their families who claim that their child’s birth defects are the result of exposure to an SSRI antidepressant.

If you or someone you love took an SSRI antidepressant during pregnancy, and your baby developed a heart defect, such as a hole in the heart, or other congenital birth defects, contact an SSRI birth defects lawyer at Carey Danis & Lowe.

Call 800.721.2519, and share your case with us.

Zoloft Lawsuit News: Injured Parties Continue to File Zoloft Birth Defects Lawsuits

By | Pharmaceutical litigation, Uncategorized, Zoloft

zoloft_heart_birth_defect_ssri_pregnancyAs a national law firm representing individuals in Zoloft birth defects lawsuits, Carey Danis & Lowe has closely been watching for news and updates in Zoloft lawsuits. Earlier this month, a plaintiff filed a Zoloft birth defects lawsuit in St. Clair County Circuit Court in Illinois claiming that her child was born with congenital heart defects. The plaintiff filed her Zoloft lawsuit citing that the maker of Zoloft, Pfizer, did not provide adequate warning about the risks associated with Zoloft use during pregnancy.

In response to the lawsuit, a Pfizer spokesperson was quoted in the Madison-St. Clair Record as saying that the pharmaceutical company intends to defend itself against the charges.

 Zoloft Birth Defects Background

In a study published in 2007 in the New England Journal of Medicine, researchers concluded that taking Zoloft (sertraline) during the first trimester of pregnancy led to two times the risk of the baby being born with a heart defect, especially a hole in the heart. In addition, the study found that the risk of a baby developing omphalocele was 5.7 times higher when exposed to Zoloft in the womb.

An atrial septal defect, also called a hole in the heart, is marked by an atypical hole between the heart’s two upper chambers. In newborn babies who develop a ventricular septal defect, a hole exists between between the heart’s two lower chambers. Omphalocele is a birth defect in which the newborn baby’s abdominal organs protrude from the belly button.

Carey Danis & Lowe Zoloft birth defects lawyers are currently taking Zoloft birth defects cases. For a free legal evaluation of your case and for assistance with filing a Zoloft birth defects lawsuit, contact Carey Danis & Lowe by calling 800.721.2519 or by submitting a personal injury claim form.

Wellbutrin Claims and Topamax Claims on the Rise at Carey Danis & Lowe

By | Pharmaceutical litigation, Topamax, Uncategorized, Wellbutrin

Published October 31, 2012 by PR Web

St. Louis, MO (PRWEB) October 31, 2012

Wellbutrin Claims and Topamax Claims on the Rise at Carey Danis & LowePharmaceutical product liability lawyers at Carey Danis & Lowe have announced that they are undertaking an investigation into Wellbutrin claims. Attorneys at Carey Danis & Lowe are asking that individuals and families contact the law firm if they feel their child, or the child of a loved one, was born with a congenital heart defect due to the use of Wellbutrin during pregnancy.

Wellbutrin is a drug manufactured by GlaxoSmithKline, and is used in to treat patients suffering from depression as well as seasonal affective disorder (SAD), attention deficit disorder (ADD), and attention deficit hyperactivity disorder (ADHD). The U.S. Food and Drug Administration (FDA) has classified Wellbutrin as a Pregnancy Category C drug.

Wellbutrin allegedly causes birth defects include oral defects, congenital heart defects, Craniosynostosis, Omphalocele, and Persistent Pulmonary Hypertension of the Newborn (PPHN).

In addition, lawyers at Carey, Danis and Lowe are taking cases related to the use the use of Topamax. Prescribed to patients suffering from epilepsy and migraine headaches, Topamax is a drug manufactured by Ortho-McNeil-Janssen Pharmaceuticals Inc. Allegedly, Topamax can cause congenital oral defects in unborn children. The FDA has categorization Topamax as a Pregnancy Category D drug. Potential oral birth defects caused by Topamax include the development of a cleft lip and cleft palette.

In past pharmaceutical product liability cases, attorneys at Carey Danis & Lowe have aided plaintiffs in winning cases against pharmaceutical giants like GlaxoSmithKline and Ortho-McNeil-Janssen Pharmaceuticals Inc.

If a newborn baby has suffered birth defects allegedly caused by exposure in the womb to either Wellbutrin or Topamax, contact an attorney at Carey Danis & Lowe at 800.721.2519, or submit a claims form about filing a Wellbutrin lawsuit or a Topamax lawsuit.

Paxil Lawsuit Report

By | Paxil, Pharmaceutical litigation, Uncategorized

Published May 11, 2012 

Paxil Lawsuit News – 5/11/2012: Paxil may be linked to serious negative side effects. If you took Paxil and believe you suffered negative side effects as a result, contact us today so that we can make arrangements for a free consultation with a law firm that is investigating cases related to the side effects of Paxil.

Paxil Lawsuit: Families are continuing to file lawsuits against Paxil because of the occurrence of side effects from Paxil. Paxil is known as an anti-depressant, specifically a selective serotonin reuptake inhibitor (SSRI). There are different chemicals in your brain and SSRIs work to prevent the nerve cells from reabsorbing serotonin, thus making serotonin in the brain more available. It is believed by some that an imbalance of chemicals is the cause of depression and one available treatment is prescribing SSRIs because serotonin is essential to mood enhancement.

While SSRIs were first prescribed to depressed patients because of the reduced amount of side effects when compared to previous generations of anti-depressants, the side effects of Paxil can be extremely dangerous. Of particular concern is Paxil and pregnancy.

Paxil Lawsuit: Taking Paxil while pregnant can affect the development of the fetus. This then results in the Paxil bad side effects. Taking Paxil during the first trimester is especially dangerous. When babies are exposed to Paxil during the first trimester, they may be born with heart problems such as atrial or ventricular septal defects.

These defects are holes in the wall that separates the heart chambers. When this heart problem exists, it makes the organ work harder than it should. It is possible that over time this defect may correct itself, but may be so severe that it will require surgery. Paxil Lawsuit

Another negative Paxil side effect includes abnormalities in the development of the abdomen (omphalocele). A type of abdominal wall defect linked to the use of Paxil is when the intestines, liver and other organs stay outside the abdomen in a sac. In a Paxil baby, the muscles in the abdominal wall (umbilical ring) do not close properly.

Once the baby is born and doing well, this side effect of Paxil will require corrective surgery. This surgery creates a cavity inside the abdomen to contain the intestinal contents. If your child has suffered from a Paxil birth defect, contact a Paxil lawyer for a consultation.

FDA Announces 10 Drugs With Severe Birth Defect Warnings

By | Pharmaceutical litigation, Uncategorized

Posted January 10, 2012 

San Diego, CA — (SBWIRE) — 01/10/2012 The drugs found on this list went through multiple tests, research experiments, and survey before the FDA classified them as dangerous to babies during pregnancy.

Zoloft (sertraline), a popular antidepressant known as a “selective serotonin reuptake inhibitor” (SSRI), is linked to dangerous side effects in users and serious birth defects (including, heart murmur, hole in the heart and other serious heart defects) if taken by pregnant women. Since 2006, the FDA has warned against the use of Zoloft and other SSRIs in pregnant mothers.

Paxil (paroxetine), one of the most widely prescribed SSRI’s for depression in adults has also been associated with serious side effects in men and women and very dangerous birth defects like heart defects that can result in death if taken by pregnant women. Also part of the 2006 study of SSRI side effects, Paxil has been identified by the FDA to be dangerous for women who are pregnant or who become pregnant.

Prozac (fluoxetine) is probably the most popular anti-depressant and SSRI prescribed by physicians over the past decade and is considered by the FDA to be highly dangerous for women who are pregnant or may become pregnant. Side effects of Prozac include heart defects, cleft palate/cleft lip, and persistent pulmonary hypertension in newborns (PPHN).

Celexa (citalopram), one of the more recent brand-named SSRI’s used to treat depression, was identified by the FDA in 2011 as being linked to very serious side effects as well as birth defects. The FDA issued a warning to adults who took higher dosages of Celexa that they are at a greater risk of deadly heart conditions including fatal heart rhythm problems. Consumer Reports released an article on the study as well.

Wellbutrin (bupropion hydrochloride), was identified by the FDA in 2009 to have links to dangerous side effects and potentially fatal birth defects. A public health advisory was released by the FDA pointing out that Wellbutrin, Chantix and Zyban may increase the risk of suicide and serious neuropsychiatric symptoms.

Lexapro (escitalopram oxalate) is prescribed by doctors to treat depression and generalized anxiety disorder and is in the group of medications classified as SSRIs or selective serotonin reuptake inhibitors. Similar to Zoloft, Paxil and Prozac, Lexapro has been linked to serious and dangerous side effects including thoughts of suicide in adults and heart defects in children from mothers who have taken these products.

Effexor (venlafaxine) is an antidepressant and anti-anxiety drug that was approved by the FDA and released on the market in 2004 as an another SSRI. Since then it has been shown to have a direct correlation with permanent and dangerous birth defects including abdominal birth defects, anal atresia, cardiac defects, limb defects and genital defects.

Diflucan (fluconazole), a powerful anti-fungal medication prescribed to women with yeast infections and other types of fungal infections in the body and organs, may be associated with rare but very serious side effects and birth defects in infants whose mothers were treated with Diflucan. The FDA reported the following possible birth defects: mis-shaped head, cleft palate/cleft lip, joint deformities and congenital heart disease and heart defects.

Topamax (topiramate) is an anti-seizure drug used to treat epileptics and is also prescribed for adults suffering migraine headaches. In 2011, the U.S. Food and Drug Administration strengthened their warning based on new data that links Topamax to severe birth defects when used while pregnant. If you or someone you know has taken or is currently taking Topamax, it is strongly urged by the FDA to discuss alternative treatments for seizures and migraines.

Depakote (divalproex sodium), another popular anti-seizure drug prescribed by doctors to treat epileptic seizures, has been reported in some studies to be linked to severe birth defects and side effects. Birth defects identified in these studies include: holes in the heart, abnormal skull formation, cleft palate/cleft lip, and spina bifida.

If you or someone close to you have taken any of the above drugs and have experienced any of the following birth defects contact a Birth Defect Attorney immediately to discuss your options.

  • Hole in Heart
  • Heart Defects
  • Cleft Lip/Cleft Palate
  • Club Foot, Fetal Death
  • Anal Atresia
  • Hypoplastic Left Heart Syndrome (HLHS)
  • Hypoplastic Right Heart Syndrome (HRHS)Lung Disease/Pulmonary Hypertension
  • Limb Defect/Genital Defect
  • Ventrical Outflow Defect
  • Atrial Septal Defect (ASD)
  • Tetralogy of the Fallot
  • Transposition of the Great Arteries
  • A Ventrical Septal Defect (VSD)
  • Pulmonary Hypertension in newborn (PPHN)
  • Additional Conditions Included…

Anyone who has taken any prescribed medications during pregnancy should discuss their options with a licensed birth defect lawyer immediately. They may be entitled to financial compensation.

Defective Drugs Trigger Avalanche of Lawsuits

By | Pharmaceutical litigation, Uncategorized

Published April 20, 2012 on LawsuitInformation.org

A lawsuit against drug manufacturer Pfizer is simmering in St. Louis, bouncing between state and federal courts while judges decide who will have the pleasure of trying the case. The class action suit is on behalf of 21 mothers who contend that their children were born with birth defects caused by the antidepressant drug Zoloft, which is made by Pfizer.

This particular lawsuit was filed in February and is still in its early stages. However, it is but the latest addition to a disturbing number of prescription drugs which are the subject of litigation due to the serious side effects they cause. Antidepressants in particular have been under fire for causing severe birth defects, up to and including fetal death.

Every drug has side effects, and consumers have the right to frank and accurate descriptions of the risks involved before they start taking a pharmaceutical product. Unfortunately, the trend has been for marketers and manufacturers to downplay or cover up the potential side effects of their wares, with sometimes disastrous results.

“Some haphazardly constructed and advertised medications are contributing to ailments that are much more difficult to overcome than the patient’s original health problem,” says John Bisnar, an attorney at California personal injury firm Bisnar Chase. “As more drug defect victims continue to come forward with debilitating injuries, more pharmaceutical manufacturing companies are being hit with large settlements and verdicts.”

Crippling Side Effects

“If you take medication, avoiding side effects is nearly impossible,” Bisnar says. “Mild side effects are of little concern, but what may seem to be a mild side effect may turn out to be something that is life-threatening. The best way to tell which is which is by keeping track of the medications that have received numerous complaints across the globe.”

A number of medications are currently the subject of lawsuits:

  • Reglan, an acid reflux drug, can cause Tardive Dyskinesia, a permanent neurological disorder characterized by involuntary facial and limb movements.
  • Actos is a diabetes medicine that has been linked to bladder cancer.
  • The painkiller Darvocet was removed from the market in 2010 after the FDA found that use of the drug can lead to heart problems and death.
  • A drug used to treat seizures and migraines, Topamax, has been found to cause birth defects like cleft palate.
  • Use of Effexor, an antidepressant, can cause heart and lung defects in babies.
  • People using Accutane to treat severe acne could be subject to liver disease, depression, ulcerative colitis and birth defects.
  • Fosamax is a drug used to treat osteoporosis but can cause a number of side effects, such as rashes, numbness, loose teeth, jaw collapse and fractured femurs.
  • The antibiotic Levaquin has been implicated in tendon ruptures. A 76-year-old plaintiff from Minnesota won $1.8 million from manufacturer Johnson & Johnson in 2010, and many more suits are pending.
  • Depakote, used to treat manic depression, has been found to cause a range of birth defects, some mild but others as serious as skeletal deformation and fetal death.
  • Another antidepressant, Lexapro, can also cause abdominal, cranial and heart-related birth defects.
  • Paxil, yet another drug used to treat depression, is linked to a laundry list of side effects for adults and newborns, all the way from dry mouth and gas to seizures, bleeding and serious heart and lung defects. As of July 2010 manufacturer GlaxoSmithKline had already spent $1 billion to resolve 800 claims of birth defects.
  • The diabetes drug Avandia, another GlaxoSmithKline product, has sparked more than 13,000 lawsuits due to its propensity for causing heart attacks.
  • A blood-thinning product called Plavix, designed to reduce the risk of heart attacks, has come under fire for actually increasing the chance that patients could suffer from heart attacks, strokes or other ailments.
  • A lawsuit over the hormone replacement drug Prempro was settled last fall after Pfizer faced a $73 million verdict for three women who said the drug gave them breast cancer. Nearly a thousand other claims are still pending.
  • Yaz, a relatively new hormonal birth control product, is alleged to cause heart attacks, strokes, blood clots, pulmonary embolisms, and gallbladder disease.
  • Cholesterol medicine Zocor is facing lawsuits claiming that the drug causes a deadly muscle disease called Rhabdomyolysis.

Attorney Jeff Lowe Speaks about Paxil Birth Defects

By | Paxil, Pharmaceutical litigation, Uncategorized

Posted April 27, 2010 

St. Louis, MO: Women who took Paxil during the first trimester of pregnancy and whose children were born with birth defects should consider speaking with an attorney about their options. Jeff Lowe, a partner at Carey Danis & Lowe, says serious birth defects have been linked to the use of Paxil during pregnancy.

Attorney Jeff Lowe Speaks about Paxil Birth Defects “The cases that we’re handling are birth defects that occurred primarily for woman who took Paxil during the first trimester,” Lowe says. “The primary birth defects are Persistent Pulmonary Hypertension of the Newborn (PPHN) and cardiac defects. Those cardiac defects are mainly atrial or septal defects—holes in the heart.”

That does not mean that babies born with other birth defects are excluded from a potential lawsuit. Pregnant women who took any antidepressants from a class of drugs known as selective serotonin reuptake inhibitors (SSRIs, a class that includes Paxil) or serotonin-norepinephrine reuptake inhibitors (SNRIs, a class that includes Effexor) and whose babies were born with birth defects may want to consider speaking to an attorney about their options.

So far the medical literature has made the strongest link between use of certain antidepressants during the first trimester and an increased risk of PPHN or cardiac defects.

“There were studies looking at SSRIs and the early literature didn’t see a connection [between SSRIs and birth defects],” Lowe says. “Then some studies began finding a connection between Paxil and birth defects such as PPHN and cardiac defects. GlaxoSmithKline [Paxil’s manufacturer] had a database they were keeping that was based on their own studies. In 2006, they published their online database, which demonstrated a higher risk in major malformations for infants exposed to Paxil in the first trimester. Additional independent peer reviewed studies confirmed the link.

“Paxil’s warning was changed in 2005 [to include the risk of birth defects]. There was an FDA warning letter issued on December 8, 2005 and a Dear Doctor letter issued in September 2005.”

The good news for potential plaintiffs is that the statute of limitations is not as much of an issue in Paxil birth defect cases as in other situations, because the person most affected by the Paxil is the child. In all states, according to Lowe, “the statute of limitations doesn’t begin to run for a minor until the minor is either 18 to 21 years old, depending on state law, so there isn’t a statute of limitations issue for most children born with birth defects as a result of their mothers taking Paxil.”

Zoloft Lawsuit Underscores Parents’ Heartbreak

By | Pharmaceutical litigation, Uncategorized, Zoloft

Posted March 18, 2012 on LawsuitInformation.org

St. Louis, MO: The recent filing of a Zoloft birth defects lawsuit underscores the pain, heartbreak and frustration evident in the plaintiffs—parents of innocent children who came into the world saddled with life-altering defects allegedly at the behest of the SSRI antidepressant, Zoloft.

It is no secret that antidepressants have been a success for pharmaceutical companies. They also represent important options in the tool belts and treating protocols of psychiatrists and medical doctors, for the treatment of depression.

However, the link between Selective Serotonin Reuptake Inhibitors and birth defects, such as Zoloft cleft palate, have driven the parents of 18 children suffering from Zoloft defects to the courts.

Reuters reports that the lawsuit filed by plaintiff Shainyah Lancaster et al last month in St. Louis, accuses Zoloft manufacturer Pfizer of suppressing information to the medical community and the public at large as to the risks associated with Zoloft when used by women of childbearing age. The lawsuit further alleges that Pfizer knew or should have known of the existence of SSRI studies, which suggested a greater risk of congenital birth defects in concert with a Zoloft pregnancy.

The Zoloft birth defects lawsuit further alleges that Pfizer was aware that Zoloft was being prescribed to pregnant women by their doctors, but that Pfizer failed to warn the medical community about the risks.

Zoloft has been the center of controversy for some time. Dr. Sidney Wolfe, of the consumer advocacy group Public Citizen, took Pfizer to task for promoting Zoloft for unapproved uses. In a statement released in October 1996, Wolfe referenced a communiqué directed to Pfizer from the US Food and Drug Administration (FDA) in August of that year, chastising Pfizer for promoting Zoloft for use in cardiac patients with depression, amongst other unapproved uses.

More recently, Peter Breggin MD, blogging in the Huffington Post on June 28, 2007, noted the spin that often accompanies the release of data. He noted that headlines and media reports surrounding the release of data from a 2007 study seemed to downplay the risks associated with SSRI drugs—Zoloft among them—even though, according to Breggin, “several severe birth defects were doubled or nearly tripled in frequency when SSRIs were taken in the first trimester. This combined with the other known toxic effects of SSRIs, including brain damage and dysfunction, make these drugs contraindicated in pregnancy.”

One of those defects—Zoloft craniosynostosis—was described in Dr. Breggin’s blog post as “the premature closing of one or more sutures or fibrous joints knitting the bones of the infant’s skull.” He noted that craniosynostosis occurs in about four per 10,000 births according to the National Institutes of Health. “A 2.8 times greater occurrence of this condition will cause 2,305 more US babies to be born each year with this birth defect as a result of their mothers taking SSRIs in the first trimester of pregnancy.”

The particular afflictions of the 18 children who allegedly suffer from Zoloft birth defects were not identified in the news reports. However, regardless of the defect suffered by the Zoloft child—Zoloft PPHN, cleft palate or Zoloft heart defects—it is assumed that their parents are facing a lifetime of stormy seas as the result of having a Zoloft newborn. As Zoloft parents face reality, they equally expect Pfizer to face the music.

Zoloft Side Effects – Birth Defects in Detail

By | Pharmaceutical litigation, Uncategorized, Zoloft

Published April 20, 2012 on LawsuitInformation.org

Side effects from Zoloft, a brand name antidepressant in a group of drugs called selective serotonin reuptake inhibitors (SSRIs), may cause life-altering and potentially life-threatening side effects / birth defects for newborns of women who took the drug during pregnancy. If your child has been harmed, contact Carey Danis & Lowe immediately. We represent hundreds of families that have been affected by Zoloft Birth Defects.

If you are looking for a compassionate law firm that is experienced with defective drugs and the adverse effects of Zoloft, contact us. Our PPHN lawyers are investigating the dangers of this drug and the possible link to the birth defect PPHN (Pulmonary Hypertension in Newborns). We are here to answer any questions you may have and help you navigate through the process of filing a Zoloft lawsuit.

ABOUT THE DANGEROUS SIDE EFFECTS OF ZOLOFT

Newborns exposed to Zoloft and other SSRIs during the first trimester of pregnancy are at risk of developing several different kinds of side effects (birth defects), including neural tube defects, cleft lip, PPHN side effects, and heart defects. Keep reading to review a complete list of the potentially dangerous side effects caused by Zoloft in newborns.

Neural Tube Defect Side Effects:

Neural tube birth defects affect the brain and spinal cord. Also called cleft spine or open spine, it is the underdevelopment of the fetal spinal column (neural tube). In an embryo, this region begins as a flat surface, and about 28 days after conception, the flat region rolls into a tube. Neural tube defects occur when this tube does not close completely, leaving an opening at the skull or vertebrae. Neural tube defects cause paralysis, incontinence, learning difficulties, loss of sensation in parts of the body, developmental delays, lack of coordination, and lack of concentration.

Omphalocele Side Effects:

An omphalocele is a birth defect caused by underdeveloped abdominal wall muscles that leaves an opening in the midgut. It causes the intestines and other organs, covered only by a thin sac, to protrude outside of this opening. While the problem can typically be corrected with surgery, many newborns with omphalocele will have additional serious side effects, including heart defects. Some of these side effects can be potentially fatal.

Cleft Lip Side Effects:

A cleft lip is a birth defect where the lip does not fuse properly during the early stages of fetal development. This side effect is characterized by a vertical fissure in one or both sides of the upper lip causes a number of difficulties, including problems with feeding, missing or malformed teeth, speech and language delay, chronic ear infections, hearing loss, and socialization.

Cleft Palate Side Effects:

A cleft palate is a birth defect in which the roof of the mouth fails to close completely in utero (at about the 6th to 9th week of pregnancy), and as a result, connects the mouth directly with the nasal cavity. Infants with a cleft palate often struggle with serious complications, including recurring ear infections, hearing loss, feeding difficulties, missing or misaligned teeth, and delays in speech and language development.

Craniosynostosis Side Effects:

Craniosynostosis is a side effect characterized by the premature fusion of an infant’s cranial sutures, the joints between the bones of the skull. The elasticity of the cranium is essential in the skull’s ability to expand in order to accommodate normal brain growth. Because the suture(s) close early, it constricts the growth of the skull (as well as the brain) and results in an abnormally shaped head. Besides irregular appearance, infants with craniosynostosis side effects may also suffer from increased intracranial pressure, seizures, and developmental delays.

Heart Defect Side Effects:

Heart defect side effects involve the structure of the heart or the blood vessels surrounding the heart. It can either obstruct blood flow in the heart or cause irregular blood flow through the heart. While some heart defects are minor and require little to no treatment, others are life-threatening and require immediate medical care in order to avoid severe consequences.

Limb Defect Side Effects:

Congenital limb defects are side effects characterized by the improper formation of an entire limb, or portion of a limb, in utero. Limb defects can involve the hand, arm, foot, leg, toes or fingers, and can present as undergrowth, overgrowth, complete absence, duplication, webbing, or as a constricting band syndrome (premature rupture of the amniotic sac that causes membranes or bands to entangle the fetus, which cuts off blood flow and tissue growth). One of the most common limb defects is club foot, a side effect in which a child is born with one or both feet smaller than normal and internally rotated at the ankle.

PPHN Side Effects:

PPHN, or persistent pulmonary hypertension of the newborn, is a side effect that causes high blood pressure in the lungs, which keeps the lungs from relaxing to allow blood to flow through properly. As a result, oxygen does not reach the bloodstream when the child breathes. Even with treatment, an infant with PPHN may continue to receive an insufficient amount of oxygen to his or her vital organs and tissues. This can potentially result in shock, seizures, heart failure, multiple organ failure, and even death.

Anal Atresia Side Effects:

Anal atresia, also referred to as imperforate anus or anal rectal malformation, is a side effect which can cause the following complications: the opening to the rectum does not properly connect to the colon; the rectum may have openings to the urethra, the bladder, the vagina, penis or scrotum; or the anus may be narrowed or missing. Although most infants with anal atresia make a full recovery after surgery, others may continue to suffer from difficulties like bowel control, constipation, and intestinal blockage. Other affected infants may experience additional side effects, particularly those of the genitals, spine or urinary tract.